Across TCGA pan-cancer cohorts, SOX18 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SOX18 data layer compared with 28 for mass-spec protein and 1 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SOX18 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SOX18 expression acts as an unfavorable survival marker.
KIRP and COAD are the cancer types where SOX18 Mutation most reproducibly stratifies survival.